These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 29544121)

  • 1. Myeloid derived-suppressor cells: their role in cancer and obesity.
    Ostrand-Rosenberg S
    Curr Opin Immunol; 2018 Apr; 51():68-75. PubMed ID: 29544121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
    Ostrand-Rosenberg S; Fenselau C
    J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.
    Clements VK; Long T; Long R; Figley C; Smith DMC; Ostrand-Rosenberg S
    J Leukoc Biol; 2018 Mar; 103(3):395-407. PubMed ID: 29345342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-Associated Myeloid Immunosuppressive Cells, Key Players in Cancer Risk and Response to Immunotherapy.
    Sanchez-Pino MD; Gilmore LA; Ochoa AC; Brown JC
    Obesity (Silver Spring); 2021 Jun; 29(6):944-953. PubMed ID: 33616242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
    Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
    Front Immunol; 2019; 10():1401. PubMed ID: 31275327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of microRNAs on myeloid-derived suppressor cells in cancer.
    Baghbani E; Noorolyai S; Duijf PHG; Silvestris N; Kolahian S; Hashemzadeh S; Baghbanzadeh Kojabad A; FallahVazirabad A; Baradaran B
    Hum Immunol; 2021 Sep; 82(9):668-678. PubMed ID: 34020831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review).
    Jiménez-Cortegana C; Gutiérrez-García C; Sánchez-Jiménez F; Vilariño-García T; Flores-Campos R; Pérez-Pérez A; Garnacho C; Sánchez-León ML; García-Domínguez DJ; Hontecillas-Prieto L; Palazón-Carrión N; De La Cruz-Merino L; Sánchez-Margalet V
    Int J Oncol; 2024 Aug; 65(2):. PubMed ID: 38940351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic changes and interaction of tumor cell, myeloid-derived suppressor cell and T cell in hypoxic microenvironment.
    Ou X; Lv W
    Future Oncol; 2020 Mar; 16(8):383-393. PubMed ID: 32067476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly.
    Betsch A; Rutgeerts O; Fevery S; Sprangers B; Verhoef G; Dierickx D; Beckers M
    Blood Rev; 2018 Nov; 32(6):490-498. PubMed ID: 29691090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-Derived Suppressor Cells.
    Gabrilovich DI
    Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Adiposity Enhances the Accumulation of MDSCs in the Tumor Microenvironment and Adipose Tissue of Pancreatic Tumor-Bearing Mice and in Immune Organs of Tumor-Free Hosts.
    Turbitt WJ; Collins SD; Meng H; Rogers CJ
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31835454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
    Abrams SI; Netherby CS; Twum DY; Messmer MN
    J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression.
    Pham DV; Park PH
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, inflammation and the immune system.
    de Heredia FP; Gómez-Martínez S; Marcos A
    Proc Nutr Soc; 2012 May; 71(2):332-8. PubMed ID: 22429824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy.
    Rapoport BL; Steel HC; Theron AJ; Smit T; Anderson R
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?
    Su Z; Ni P; Zhou C; Wang J
    Scand J Immunol; 2016 Nov; 84(5):255-261. PubMed ID: 27541573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine Cathepsins in Tumor-Associated Immune Cells.
    Jakoš T; Pišlar A; Jewett A; Kos J
    Front Immunol; 2019; 10():2037. PubMed ID: 31555270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasticity and biological diversity of myeloid derived suppressor cells.
    Ben-Meir K; Twaik N; Baniyash M
    Curr Opin Immunol; 2018 Apr; 51():154-161. PubMed ID: 29614426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.